Sagent Pharmaceuticals

Sagent Pharmaceuticals is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients. Sagent currently has more than 200 products in development.

Schaumburg, US
440 (est)+250%
Sagent Pharmaceuticals was founded in 2006 and is headquartered in Schaumburg, US

Sagent Pharmaceuticals Locations

Schaumburg, US

Sagent Pharmaceuticals Metrics

Sagent Pharmaceuticals Summary

Market capitalization

$716 M

Closing share price

Sagent Pharmaceuticals's current market capitalization is $716 M.

Sagent Pharmaceuticals Financials

Sagent Pharmaceuticals's revenue is $318 M in FY, 2015 which is 10.14% increase from the previous period.
FY, 2013FY, 2014FY, 2015


$245 M$289 M$318 M

Gross profit

$77.5 M$86.2 M$87.7 M

Operating income

$29 M$15.1 M$-47.1 M

Operating expense total

$54.1 M$67.1 M$84.7 M

Net Income

$29.6 M$39.9 M$-21.9 M

Operating cash flow

$14.6 M$13.3 M$-26.7 M

    Sagent Pharmaceuticals News

    Sagent Pharmaceuticals Company Life

    You may also be interested in